Ithaca, NY, May 23, 2013 --(PR.com
)-- MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed agreements with EMBLEM, the commercial subsidiary of the EMBL (the European Molecular Biology Laboratory).
“As in many research fields, advances in structural biology rely on the performance of the investigation tools, that’s why the development of new instruments is an essential part of EMBL’s mission,” says Florent Cipriani, who heads the synchrotron instrumentation team at EMBL in Grenoble, France. “Together with Josan Marquez, who is charge of the high throughput crystallization facility we developed CrystalDirect®, a new system that enables full automation of the macromolecular X-ray crystallography process. The partnership with MiTeGen enables us to offer high quality consumables to the scientific community worldwide.”
Under the agreements, MiTeGen and the EMBL outstation in Grenoble will collaborate on the continued development of thin-film crystallization plates for protein crystallization. Additionally, MiTeGen will act as the exclusive worldwide distributor of EMBL’s CrystalDirect® plates, and the non-exclusive distributor of other EMBL products such as the SC3 basket for cryo-storage and transport of samples.
Customers can order MiTeGen In-Situ-01 plates at this time and can expect to see late stage prototypes of the CrystalDirect® plate at ACA2013 this summer, with commercial sales of CrystalDirect® plates following closely afterward.
“The development of thin-film plates such as MiTeGen’s In-Situ-01™ plate, and EMBL’s CrystalDirect® Plate bring significant new capabilities to crystallographers,” says Robert Newman, CEO of MiTeGen. “These include an unsurpassed ability to perform X-ray and UV studies on crystals in-situ; the ability to harvest crystals automatically with EMBL’s CrystalDirect® system; and vastly improved plate handling capabilities. The collaboration of MiTeGen and the EMBL for the further development in this arena is a great match for bringing unique advancements in these tools to the scientific community. We look forward to the continued development of our partnership with EMBL.”
The European Molecular Biology Laboratory is a non-profit organization and a basic research institute funded by public research monies from 20 member states and one associate member. Research at EMBL is conducted by approximately 85 independent groups covering the spectrum of molecular biology.
More information can be found at www.embl.de
HTX lab: https://embl.fr/htxlab/
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). EMBLEM identifies, protects and commercialises the intellectual property developed in the EMBL-world, from EMBL-alumni and from non-EMBL third parties. EMBLEM facilitates and accelerates the transfer of innovative technology from basic research to industry by working closely with industrial partners spanning the biotech, pharmaceutical, IT and mechanical/electrical engineering markets. More information can be found at www.embl-em.de
MiTeGen designs, manufactures and distributes products for crystallization, crystallography and X-ray diffraction of proteins, viruses and small molecule/inorganic compounds, and for manipulation and measurement of small samples in cell biology, histology, clinical diagnostics, entomology, archaeology, art restoration and geology. Their customers include academic, medical, pharmaceutical, government and industrial laboratories in more than 40 countries.
Founded in 2004, MiTeGen is based in Ithaca, NY.
More information can be found at www.mitegen.com.